Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 2/1999

01-06-1999

An Observed Performance Test of Medication Management Ability in HIV: Relation to Neuropsychological Status and Medication Adherence Outcomes

Authors: Steven M. Albert, Christine M. Weber, George Todak, Carmen Polanco, Ronda Clouse, Martin McElhiney, Judith Rabkin, Yaakov Stern, Karen Marder

Published in: AIDS and Behavior | Issue 2/1999

Login to get access
Metadata
Title
An Observed Performance Test of Medication Management Ability in HIV: Relation to Neuropsychological Status and Medication Adherence Outcomes
Authors
Steven M. Albert
Christine M. Weber
George Todak
Carmen Polanco
Ronda Clouse
Martin McElhiney
Judith Rabkin
Yaakov Stern
Karen Marder
Publication date
01-06-1999
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
AIDS and Behavior / Issue 2/1999
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1023/A:1025483806464

Other articles of this Issue 2/1999

AIDS and Behavior 2/1999 Go to the issue

OriginalPaper

Childhood Sexual Abuse and Its Relationship to High-Risk Behavior in Women Volunteering for an HIV and STD Prevention Intervention

OriginalPaper

Fear of AIDS: Assessment and Implications for Promoting Safer Sex

OriginalPaper

Estimating the Impact of Sexually Transmitted HIV Prevention Interventions: A Comparison of the Proportion of Unprotected Acts to a Regression-Based Approach

OriginalPaper

Early Appointment Adherence Among Persons Living with HIV

OriginalPaper

Screening Clinical Depression in HIV-Seropositive Patients Using the Hospital Anxiety and Depression Scale

OriginalPaper

Patterns and Correlates of Risky Behavior Among HIV+ Gay Men: Are They Really Different from HIV− Men?
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits